Top-News
  • Watchlist
  • Glocke

  • CAC 40 Index

    7.562,89 -2,61% -202,8274
    22:10:21 Uhr Ariva Indikation aktualisieren | Orderbuch | Mehr Kurse »
    WKN: 969400
    ISIN: FR0003500008
    Typ: Index

    Weiter abwärts? Short handeln - Jetzt mit Hebel 9,37: MK4SMK
    Werbung

    Ad-hocs

    07.02.25 - GlobeNewswire
    237 Aufrufe
    Press Release: Execution of a share buyback agreement for up to €2 billion
    Execution of a share buyback agreement for up to €2 billion Paris, February 7, 2025. On January 30, 2025 , Sanofi announced its intention to execute a share buyback program in ...
    06.02.25 - GlobeNewswire
    352 Aufrufe
    2024 Annual Results
    Solid +5.1% Growth in a Challenging Context
    06.02.25 - GlobeNewswire
    270 Aufrufe
    ArcelorMittal S.A.: ArcelorMittal reports fourth quarter 2024 and full year 2024 results
    Luxembourg, February 6 , 20 25 - ArcelorMittal (referred to as “ArcelorMittal” or the “Company” or the "Group") (MT (New York, Amsterdam, Paris, Luxembourg), MTS (Madrid)), the world’s ...
    04.02.25 - GlobeNewswire
    215 Aufrufe
    Publicis Groupe : Full Year 2024 Results
    Full Year 2024 Results
    03.02.25 - GlobeNewswire
    290 Aufrufe
    Agreement Between L’Oréal and Sanofi for the Repurchase by Sanofi of 2.3% of Its Own Shares Held by L’Oréal
    AGREEMENT BETWEEN L’ORÉAL AND SANOFI FOR THE REPURCHASE BY SANOFI OF 2.3% OF ITS OWN SHARES HELD BY L’ORÉAL
    03.02.25 - GlobeNewswire
    301 Aufrufe
    Press Release: Sanofi announces buy back of shares from L’Oréal
    Sanofi announces buy back of shares from L’Oréal
    31.01.25 - GlobeNewswire
    298 Aufrufe
    Press Release: Sarclisa is the first anti-CD38 treatment approved in China for patients with newly diagnosed multiple myeloma ineligible for transplant
    Sarclisa is the first anti-CD38 treatment approved in China for patients with newly diagnosed multiple myeloma ineligible for transplant
    30.01.25 - GlobeNewswire
    235 Aufrufe
    Press Release: Q4 sales growth of 10.3%, 2024 business EPS guidance exceeded, and strong business EPS rebound expected in 2025
    Sanofi: Q4 sales growth of 10.3%, 2024 business EPS guidance exceeded, and strong business EPS rebound expected in 2025
    28.01.25 - GlobeNewswire
    258 Aufrufe
    ArcelorMittal announces the publication of its fourth quarter and full year 2024 sell-side analyst consensus figures 
    ArcelorMittal (‘the Company’) today announces the publication of its fourth quarter and full year 2024 sell-side analyst consensus figures.
    27.01.25 - EQS
    248 Aufrufe
    EQS-Adhoc: Airbus reports share buyback transactions 20-24 January 2025
    EQS-​Ad-hoc: Airbus SE / Key word(s): Share Buyback Airbus reports share buyback transactions 20-24 January 2025 27-Jan-2025 / 18:00 CET/CEST Disclosure of an inside ...
    22.01.25 - GlobeNewswire
    204 Aufrufe
    Press Release: Sarclisa approved in the EU as the first anti-CD38 therapy in combination with standard-of-care VRd to treat transplant-ineligible newly diagnosed multiple myeloma
    Sarclisa approved in the EU as the first anti-CD38 therapy in combination with standard-​of-care VRd to treat transplant-​ineligible newly diagnosed multiple myeloma Approval is ...
    21.01.25 - GlobeNewswire
    179 Aufrufe
    Press Release: Opella reaches study milestone for Cialis
    Opella reaches study milestone for Cialis
    20.01.25 - EQS
    279 Aufrufe
    EQS-Adhoc: Airbus reports share buyback transactions 13-17 January 2025
    EQS-​Ad-hoc: Airbus SE / Key word(s): Share Buyback Airbus reports share buyback transactions 13-17 January 2025 20-Jan-2025 / 17:45 CET/CEST Disclosure of an inside ...
    13.01.25 - EQS
    213 Aufrufe
    EQS-Adhoc: Airbus reports share buyback transactions 3-10 January 2025
    EQS-​Ad-hoc: Airbus SE / Key word(s): Share Buyback Airbus reports share buyback transactions 3-10 January 2025 13-Jan-2025 / 17:45 CET/CEST Disclosure of an inside ...
    13.01.25 - GlobeNewswire
    238 Aufrufe
    Press Release: Sarclisa obtains first approval in China for the treatment of adult patients with relapsed or refractory multiple myeloma
    Sarclisa obtains first approval in China for the treatment of adult patients with relapsed or refractory multiple myeloma
    09.01.25 - GlobeNewswire
    233 Aufrufe
    Press Release: New Sarclisa subcutaneous formulation met co-primary endpoints in the IRAKLIA phase 3 study in multiple myeloma
    New Sarclisa subcutaneous formulation met co-​primary endpoints in the IRAKLIA phase 3 study in multiple myeloma Sarclisa SC formulation added to Pd for the treatment of R/R ...
    03.01.25 - EQS
    395 Aufrufe
    EQS-Adhoc: Airbus reports share buybacks 23 Dec 2024 to 2 Jan 2025
    EQS-​Ad-hoc: Airbus SE / Key word(s): Share Buyback Airbus reports share buybacks 23 Dec 2024 to 2 Jan 2025 03-Jan-2025 / 17:45 CET/CEST Disclosure of an inside information ...
    23.12.24 - EQS
    336 Aufrufe
    EQS-Adhoc: Airbus reports share buyback transactions 16-20 December 2024
    EQS-​Ad-hoc: Airbus SE / Key word(s): Share Buyback Airbus reports share buyback transactions 16-20 December 2024 23-Dec-2024 / 17:45 CET/CEST Disclosure of an inside ...
    23.12.24 - GlobeNewswire
    464 Aufrufe
    Press Release: Sanofi initiates phase 3 program for PCV21 and expands collaboration with SK bioscience for next-generation pneumococcal conjugate vaccines
    Sanofi initiates phase 3 program for PCV21 and expands collaboration with SK bioscience for next-​generation pneumococcal conjugate vaccines Pneumococcal disease remains a ...
    19.12.24 - GlobeNewswire
    300 Aufrufe
    Presse release: Jean-Paul Kress to join Sanofi's Board of Directors
    Jean-Paul Kress to join Sanofi's Board of Directors

    Newssuche

    Videos

    newspaper
    13:00 Uhr -0,57%
    Technical Trading: Gold Long zum Wochenende
    Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 7 Laufzeit: OpenEnd Einstieg: Market ... Mehr »